Color Genomics, the genetics testing company, is partnering with Alphabet’s health technology focused subsidiary, Verily Life Sciences, to provide information from its genetic tests to the company’s Baseline Health Study participants.

The emphasis from both companies is on providing “actionable” results.

While genetic testing services have caught the public’s imagination for their ability to provide insights into an individual’s ancestry, the technology has proven to be less effective in providing insights on health that accurate enough to be clinically relevant.

Through the partnership, Project Baseline Health participants will be able to access Color’s physician-ordered genomics testing services and the company’s board-certified genetic counselors and pharmacists to help them understand what their genetic tests indicate about their risks for certain cancers,…

Read More

Leave a Reply

Your email address will not be published.